← Back
$AURA All transactions

Aura Biosciences, Inc.

A

$ Value

$0

Shares

17,000

Price

$0

Filed

Jun 18

Insider

Name

Srivastava Sapna

Title

CIK

0001569226

Roles

Director

Transaction Details

Transaction Date

2025-06-17

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

17,000

Footnotes

These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date. | This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Filing Info

Accession No.

0000950170-25-087891

Form Type

4

Issuer CIK

0001501796

Srivastava Sapna's History

Date Ticker Type Value
2025-10-28 TRML U
2025-10-28 TRML D
2025-10-28 TRML D
2025-10-28 TRML D
2025-07-30 ALMS A $0
2025-06-18 NUVL A $0
2025-06-18 NUVL A $0
2025-06-17 AURA A $0
2025-06-17 AURA A $0
2025-06-04 TRML A $0

Other Insiders at AURA (90d)

Insider Bought Sold Last
Kilroy Conor
See Remarks
$143K 2026-04-16
Plavsic Mark
Chief Technology Officer
$80K 2026-02-17
de los Pinos Elisabet
See Remarks
$241K 2026-02-17
Hopkins Janet Jill
Chief Medical Officer
$103K 2026-02-17
Elazzouzi Amy
Senior Vice President, Finance
$43K 2026-02-17